Navigate Up

Cardiothoracic Research and Clinical Trials

The UPMC Esophageal and Lung Institute conducts research in a number of key areas. Some research focuses on providing alternative sources for organs and reducing or eliminating the need for organ transplantation.

UPMC, in collaboration with the University of Pittsburgh School of Medicine, enjoys global recognition as one of the world’s most active facilities for heart and lung transplantation and cardiac-assist devices.

Our investigators are constantly researching new therapies and procedures to help those with cardiothoracic diseases and disorders.

Key Areas of Research

Artificial organs

UPMC implanted the nation’s second Jarvik Artificial Heart in a patient as a bridge to transplantation in 1985. Five years later, through our Artificial Heart Program, UPMC became the first health care facility in the world to discharge a patient with a newly implanted ventricular assist device (VAD).

Since then, our highly experienced, specialized surgeons have implanted VADs in approximately 600 people with heart failure.

VAD implantation has provided a chance at renewed life for critically ill patients suffering from acute congestive heart failure or cardiogenic shock.

Already pioneers in the development of new and innovative artificial heart technology, researchers at the McGowan Institute for Regenerative Medicine are expanding their horizons and developing artificial systems that can take over for failing lungs and livers as well.

Like VAD technology, these systems will one day act as a bridge to transplantation as people await their new lungs or liver. They may even serve as a bridge to recovery, allowing organs to heal while the device is temporarily in place. Still others may benefit permanently from an implantation of one of these systems, eliminating the need for an organ transplant altogether.

Cell therapies and regenerative medicine

UPMC researchers and physicians are actively exploring the discipline of regenerative medicine and cell therapy. This field of research focuses on developing technology that will allow physicians to simply infuse young, healthy cells into a diseased organ rather than replacing it with a whole new one through transplantation surgery.

A recognized pioneer in regenerative medicine, the McGowan Institute develops and transfers scientific research and innovative clinical protocols while pursuing rapid FDA authorization for commercialization of its technologies.

This rapidly emerging and expanding field of research seeks to address diseases and disorders through:

  • Tissue engineering
  • Artificial medical devices
  • Stem cell research
  • Combination therapies

Regenerative medicine-based therapeutics are currently in use or in clinical trials to address many diseases, including:

  • Liver disease
  • Heart failure
  • Orthopaedic injuries
  • Organ failure
  • Spinal cord injuries
  • Diabetes
  • Sickle cell disease
  • Parkinson’s and Alzheimer’s diseases

Contact Us

To refer a patient or to learn more about our programs, call the phone numbers below.

Division of Cardiac Surgery
Phone: 412-648-6200

Division of Pediatric Cardiac Surgery
Phone: 412-692-5218
Fax: 412-692-5817

Division of Cardiothoracic Transplantation
Phone: 412-648-6202

Division of Thoracic and Foregut Surgery
Phone: 412-647-7555

 

Additional Resources

Video Resources

Watch Dr. Robert Kormos' podcast about ventricular assist devices, produced by the Discovery channel.

©  UPMC | Affiliated with the University of Pittsburgh Schools of the Health Sciences
Supplemental content provided by A.D.A.M. Health Solutions. All rights reserved.

For help in finding a doctor or health service that suits your needs, call the UPMC Referral Service at 412-647-UPMC (8762) or 1-800-533-UPMC (8762). Select option 1.

UPMC is an equal opportunity employer. UPMC policy prohibits discrimination or harassment on the basis of race, color, religion, ancestry, national origin, age, sex, genetics, sexual orientation, marital status, familial status, disability, veteran status, or any other legally protected group status. Further, UPMC will continue to support and promote equal employment opportunity, human dignity, and racial, ethnic, and cultural diversity. This policy applies to admissions, employment, and access to and treatment in UPMC programs and activities. This commitment is made by UPMC in accordance with federal, state, and/or local laws and regulations.

Medical information made available on UPMC.com is not intended to be used as a substitute for professional medical advice, diagnosis, or treatment. You should not rely entirely on this information for your health care needs. Ask your own doctor or health care provider any specific medical questions that you have. Further, UPMC.com is not a tool to be used in the case of an emergency. If an emergency arises, you should seek appropriate emergency medical services.

For UPMC Mercy Patients: As a Catholic hospital, UPMC Mercy abides by the Ethical and Religious Directives for Catholic Health Care Services, as determined by the United States Conference of Catholic Bishops. As such, UPMC Mercy neither endorses nor provides medical practices and/or procedures that contradict the moral teachings of the Roman Catholic Church.

© UPMC
Pittsburgh, PA, USA UPMC.com